{"assetProfile": {"address1": "675 West Kendall Street", "address2": "Henri A. Termeer Square", "city": "Cambridge", "state": "MA", "zip": "02142", "country": "United States", "phone": "617 551 8200", "fax": "617 551 8101", "website": "https://www.alnylam.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference. It offers ONPATTRO and AMVUTTRA for hereditary transthyretin-mediated amyloidosis; GIVLAARI for acute hepatic porphyria; OXLUMO for primary hyperoxaluria type 1; and Leqvio for hypercholesterolemia. It also develops vutrisiran, which is in phase III clinical trial for transthyretin amyloidosis (ATTR) with cardiomyopathy; Nucresiran that is in phase I clinical trial for ATTR amyloidosis; Fitusiran, which is in phase III clinical trial for hemophilia; cemdisiran that is in phase III clinical trial for Myasthenia Gravis and paroxysmal nocturnal hemoglobinuria, and geographic atrophy; and ALN-6400, which is in phase I clinical trial for bleeding disorders. In addition, the company is also developing Zilebesiran, which is in phase II clinical trial for hypertension; Rapirosiran that is in phase II clinical trial for Metabolic dysfunction-associated steatohepatitis; ALN-4324, which is in phase I clinical trial for type 2 diabetes mellitus; ALN-PNP that is in phase I clinical trial for non-alcoholic fatty liver disease; ALN-APOC3, which is in phase I clinical trial for dyslipidemia; Mivelsiran that is in phase II clinical trial for cerebral amyloid angiopathy, and phase I clinical trial for Alzheimer's disease; and ALN-HTT02 that is in phase I clinical trial for Huntington's disease. Further, it develops ALN-SOD, which is in phase II clinical trial for SOD1 Amyotrophic lateral sclerosis; Elebsiran that is in phase II clinical trial for Hepatitis B and D virus infections; ALN-BCAT that is in phase I clinical trial for hepatocellular carcinoma; and ALN-ANG3. It has collaborations with Regeneron Pharmaceuticals, Inc.; Roche Holding AG; Regeneron Pharmaceuticals, Inc.; Sanofi S.A.; Novartis AG; PeptiDream, Inc; Dicerna Pharmaceuticals, Inc.; and Ionis Pharmaceuticals, Inc. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.", "fullTimeEmployees": 2230, "companyOfficers": [{"maxAge": 1, "name": "Dr. Yvonne L. Greenstreet M.B.A., M.D.", "age": 61, "title": "CEO & Director", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": {"raw": 4253570, "fmt": "4.25M", "longFmt": "4,253,570"}, "exercisedValue": {"raw": 5727380, "fmt": "5.73M", "longFmt": "5,727,380"}, "unexercisedValue": {"raw": 17191740, "fmt": "17.19M", "longFmt": "17,191,740"}}, {"maxAge": 1, "name": "Dr. Phillip A. Sharp Ph.D.", "age": 79, "title": "Co-Founder, Member of the Scientific Advisory Board", "yearBorn": 1945, "fiscalYear": 2024, "totalPay": {"raw": 105000, "fmt": "105k", "longFmt": "105,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Jeffrey V. Poulton M.B.A.", "age": 56, "title": "CFO & Executive VP", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": {"raw": 1433740, "fmt": "1.43M", "longFmt": "1,433,740"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 26040664, "fmt": "26.04M", "longFmt": "26,040,664"}}, {"maxAge": 1, "name": "Dr. Kevin Joseph Fitzgerald Ph.D.", "age": 56, "title": "Executive VP, Chief Scientific Officer and Head of Early Research & Early Development", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": {"raw": 1225300, "fmt": "1.23M", "longFmt": "1,225,300"}, "exercisedValue": {"raw": 3769372, "fmt": "3.77M", "longFmt": "3,769,372"}, "unexercisedValue": {"raw": 6797953, "fmt": "6.8M", "longFmt": "6,797,953"}}, {"maxAge": 1, "name": "Dr. Pushkal P. Garg M.D.", "age": 56, "title": "EVP of Development & Medical Affairs and Chief Research & Dev. Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": {"raw": 1421120, "fmt": "1.42M", "longFmt": "1,421,120"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 22391564, "fmt": "22.39M", "longFmt": "22,391,564"}}, {"maxAge": 1, "name": "Mr. Tolga  Tanguler M.B.A.", "age": 51, "title": "Executive VP & Chief Commercial Officer", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": {"raw": 1306670, "fmt": "1.31M", "longFmt": "1,306,670"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 5872630, "fmt": "5.87M", "longFmt": "5,872,630"}}, {"maxAge": 1, "name": "Mr. Timothy J. Maines", "title": "Chief Technical Operations & Quality Officer", "fiscalYear": 2024, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Piyush  Sharma J.D.", "title": "Chief Ethics & Compliance Officer", "fiscalYear": 2024, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Bryan Andrew Supran J.D.", "age": 54, "title": "Chief Legal Officer", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Christine Regan Akinc", "age": 43, "title": "Chief Corporate Communications Officer", "yearBorn": 1981, "fiscalYear": 2024, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 4, "boardRisk": 2, "compensationRisk": 3, "shareHolderRightsRisk": 6, "overallRisk": 4, "governanceEpochDate": 1761955200, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400}, "calendarEvents": {"maxAge": 1, "earnings": {"earningsDate": [{"raw": 1761827400, "fmt": "2025-10-30"}], "earningsCallDate": [{"raw": 1761827400, "fmt": "2025-10-30"}], "isEarningsDateEstimate": false, "earningsAverage": {"raw": 1.63576, "fmt": "1.64"}, "earningsLow": {"raw": 0.67, "fmt": "0.67"}, "earningsHigh": {"raw": 2.63, "fmt": "2.63"}, "revenueAverage": {"raw": 1160459550, "fmt": "1.16B", "longFmt": "1,160,459,550"}, "revenueLow": {"raw": 909000000, "fmt": "909M", "longFmt": "909,000,000"}, "revenueHigh": {"raw": 1611000000, "fmt": "1.61B", "longFmt": "1,611,000,000"}}, "exDividendDate": {}, "dividendDate": {}}, "earningsTrend": {"trend": [{"maxAge": 1, "period": "0q", "endDate": "2025-12-31", "growth": {"raw": 26.262701, "fmt": "2,626.27%"}, "earningsEstimate": {"avg": {"raw": 1.63576, "fmt": "1.64"}, "low": {"raw": 0.67, "fmt": "0.67"}, "high": {"raw": 2.63, "fmt": "2.63"}, "yearAgoEps": {"raw": 0.06, "fmt": "0.06"}, "numberOfAnalysts": {"raw": 11, "fmt": "11", "longFmt": "11"}, "growth": {"raw": 26.262701, "fmt": "2,626.27%"}, "earningsCurrency": "USD"}, "revenueEstimate": {"avg": {"raw": 1160459550, "fmt": "1.16B", "longFmt": "1,160,459,550"}, "low": {"raw": 909000000, "fmt": "909M", "longFmt": "909,000,000"}, "high": {"raw": 1611000000, "fmt": "1.61B", "longFmt": "1,611,000,000"}, "numberOfAnalysts": {"raw": 23, "fmt": "23", "longFmt": "23"}, "yearAgoRevenue": {"raw": 593166000, "fmt": "593.17M", "longFmt": "593,166,000"}, "growth": {"raw": 0.9564, "fmt": "95.64%"}, "revenueCurrency": "USD"}, "epsTrend": {"current": {"raw": 1.63576, "fmt": "1.64"}, "7daysAgo": {"raw": 2.44862, "fmt": "2.45"}, "30daysAgo": {"raw": 2.27865, "fmt": "2.28"}, "60daysAgo": {"raw": 2.24588, "fmt": "2.25"}, "90daysAgo": {"raw": 2.03615, "fmt": "2.04"}, "epsTrendCurrency": "USD"}, "epsRevisions": {"upLast7days": {"raw": 2, "fmt": "2", "longFmt": "2"}, "upLast30days": {"raw": 2, "fmt": "2", "longFmt": "2"}, "downLast30days": {"raw": 2, "fmt": "2", "longFmt": "2"}, "downLast7Days": {"raw": 0, "fmt": null, "longFmt": "0"}, "downLast90days": {}, "epsRevisionsCurrency": "USD"}}, {"maxAge": 1, "period": "+1q", "endDate": "2026-03-31", "growth": {"raw": 227.0, "fmt": "22,700.00%"}, "earningsEstimate": {"avg": {"raw": 2.26, "fmt": "2.26"}, "low": {"raw": 1.55, "fmt": "1.55"}, "high": {"raw": 3.12, "fmt": "3.12"}, "yearAgoEps": {"raw": -0.01, "fmt": "-0.01"}, "numberOfAnalysts": {"raw": 5, "fmt": "5", "longFmt": "5"}, "growth": {"raw": 227.0, "fmt": "22,700.00%"}, "earningsCurrency": "USD"}, "revenueEstimate": {"avg": {"raw": 1242815110, "fmt": "1.24B", "longFmt": "1,242,815,110"}, "low": {"raw": 1106000000, "fmt": "1.11B", "longFmt": "1,106,000,000"}, "high": {"raw": 1462900000, "fmt": "1.46B", "longFmt": "1,462,900,000"}, "numberOfAnalysts": {"raw": 9, "fmt": "9", "longFmt": "9"}, "yearAgoRevenue": {"raw": 594189000, "fmt": "594.19M", "longFmt": "594,189,000"}, "growth": {"raw": 1.0916001, "fmt": "109.16%"}, "revenueCurrency": "USD"}, "epsTrend": {"current": {"raw": 2.26, "fmt": "2.26"}, "7daysAgo": {"raw": 1.97, "fmt": "1.97"}, "30daysAgo": {"raw": 1.838, "fmt": "1.84"}, "60daysAgo": {"raw": 1.838, "fmt": "1.84"}, "90daysAgo": {"raw": 1.6025, "fmt": "1.6"}, "epsTrendCurrency": "USD"}, "epsRevisions": {"upLast7days": {"raw": 1, "fmt": "1", "longFmt": "1"}, "upLast30days": {"raw": 1, "fmt": "1", "longFmt": "1"}, "downLast30days": {"raw": 0, "fmt": null, "longFmt": "0"}, "downLast7Days": {"raw": 0, "fmt": null, "longFmt": "0"}, "downLast90days": {}, "epsRevisionsCurrency": "USD"}}, {"maxAge": 1, "period": "0y", "endDate": "2025-12-31", "growth": {"raw": 247.15, "fmt": "24,715.00%"}, "earningsEstimate": {"avg": {"raw": 4.923, "fmt": "4.92"}, "low": {"raw": 3.76, "fmt": "3.76"}, "high": {"raw": 5.99, "fmt": "5.99"}, "yearAgoEps": {"raw": -0.02, "fmt": "-0.02"}, "numberOfAnalysts": {"raw": 10, "fmt": "10", "longFmt": "10"}, "growth": {"raw": 247.15, "fmt": "24,715.00%"}, "earningsCurrency": "USD"}, "revenueEstimate": {"avg": {"raw": 3690121110, "fmt": "3.69B", "longFmt": "3,690,121,110"}, "low": {"raw": 3424000000, "fmt": "3.42B", "longFmt": "3,424,000,000"}, "high": {"raw": 4227000000, "fmt": "4.23B", "longFmt": "4,227,000,000"}, "numberOfAnalysts": {"raw": 26, "fmt": "26", "longFmt": "26"}, "yearAgoRevenue": {"raw": 2248243000, "fmt": "2.25B", "longFmt": "2,248,243,000"}, "growth": {"raw": 0.64129996, "fmt": "64.13%"}, "revenueCurrency": "USD"}, "epsTrend": {"current": {"raw": 4.923, "fmt": "4.92"}, "7daysAgo": {"raw": 4.24708, "fmt": "4.25"}, "30daysAgo": {"raw": 3.93581, "fmt": "3.94"}, "60daysAgo": {"raw": 3.91766, "fmt": "3.92"}, "90daysAgo": {"raw": 3.86245, "fmt": "3.86"}, "epsTrendCurrency": "USD"}, "epsRevisions": {"upLast7days": {"raw": 1, "fmt": "1", "longFmt": "1"}, "upLast30days": {"raw": 5, "fmt": "5", "longFmt": "5"}, "downLast30days": {"raw": 1, "fmt": "1", "longFmt": "1"}, "downLast7Days": {"raw": 1, "fmt": "1", "longFmt": "1"}, "downLast90days": {}, "epsRevisionsCurrency": "USD"}}, {"maxAge": 1, "period": "+1y", "endDate": "2026-12-31", "growth": {"raw": 1.2251999, "fmt": "122.52%"}, "earningsEstimate": {"avg": {"raw": 10.95468, "fmt": "10.95"}, "low": {"raw": 6.44, "fmt": "6.44"}, "high": {"raw": 19.87, "fmt": "19.87"}, "yearAgoEps": {"raw": 4.923, "fmt": "4.92"}, "numberOfAnalysts": {"raw": 13, "fmt": "13", "longFmt": "13"}, "growth": {"raw": 1.2251999, "fmt": "122.52%"}, "earningsCurrency": "USD"}, "revenueEstimate": {"avg": {"raw": 5320488760, "fmt": "5.32B", "longFmt": "5,320,488,760"}, "low": {"raw": 4339300000, "fmt": "4.34B", "longFmt": "4,339,300,000"}, "high": {"raw": 7415600000, "fmt": "7.42B", "longFmt": "7,415,600,000"}, "numberOfAnalysts": {"raw": 25, "fmt": "25", "longFmt": "25"}, "yearAgoRevenue": {"raw": 3690121110, "fmt": "3.69B", "longFmt": "3,690,121,110"}, "growth": {"raw": 0.4418, "fmt": "44.18%"}, "revenueCurrency": "USD"}, "epsTrend": {"current": {"raw": 10.95468, "fmt": "10.95"}, "7daysAgo": {"raw": 10.60853, "fmt": "10.61"}, "30daysAgo": {"raw": 9.81395, "fmt": "9.81"}, "60daysAgo": {"raw": 9.45234, "fmt": "9.45"}, "90daysAgo": {"raw": 7.69193, "fmt": "7.69"}, "epsTrendCurrency": "USD"}, "epsRevisions": {"upLast7days": {"raw": 1, "fmt": "1", "longFmt": "1"}, "upLast30days": {"raw": 4, "fmt": "4", "longFmt": "4"}, "downLast30days": {"raw": 2, "fmt": "2", "longFmt": "2"}, "downLast7Days": {"raw": 1, "fmt": "1", "longFmt": "1"}, "downLast90days": {}, "epsRevisionsCurrency": "USD"}}], "defaultMethodology": "nongaap", "maxAge": 1}, "earningsHistory": {"history": [{"maxAge": 1, "epsActual": {"raw": 0.06, "fmt": "0.06"}, "epsEstimate": {"raw": -0.1411, "fmt": "-0.14"}, "epsDifference": {"raw": 0.2, "fmt": "0.2"}, "surprisePercent": {"raw": 1.4252, "fmt": "142.52%"}, "quarter": {"raw": 1735603200, "fmt": "2024-12-31"}, "currency": "USD", "period": "-4q"}, {"maxAge": 1, "epsActual": {"raw": -0.01, "fmt": "-0.01"}, "epsEstimate": {"raw": -0.36943, "fmt": "-0.37"}, "epsDifference": {"raw": 0.36, "fmt": "0.36"}, "surprisePercent": {"raw": 0.97290003, "fmt": "97.29%"}, "quarter": {"raw": 1743379200, "fmt": "2025-03-31"}, "currency": "USD", "period": "-3q"}, {"maxAge": 1, "epsActual": {"raw": 0.32, "fmt": "0.32"}, "epsEstimate": {"raw": 0.14573, "fmt": "0.15"}, "epsDifference": {"raw": 0.17, "fmt": "0.17"}, "surprisePercent": {"raw": 1.1958001, "fmt": "119.58%"}, "quarter": {"raw": 1751241600, "fmt": "2025-06-30"}, "currency": "USD", "period": "-2q"}, {"maxAge": 1, "epsActual": {"raw": 2.9, "fmt": "2.9"}, "epsEstimate": {"raw": 1.74574, "fmt": "1.75"}, "epsDifference": {"raw": 1.15, "fmt": "1.15"}, "surprisePercent": {"raw": 0.66120005, "fmt": "66.12%"}, "quarter": {"raw": 1759190400, "fmt": "2025-09-30"}, "currency": "USD", "period": "-1q"}], "defaultMethodology": "nongaap", "maxAge": 86400}, "financialData": {"maxAge": 86400, "currentPrice": {"raw": 434.07, "fmt": "434.07"}, "targetHighPrice": {"raw": 580.0, "fmt": "580.00"}, "targetLowPrice": {"raw": 296.27, "fmt": "296.27"}, "targetMeanPrice": {"raw": 484.0123, "fmt": "484.01"}, "targetMedianPrice": {"raw": 497.5, "fmt": "497.50"}, "recommendationMean": {"raw": 1.7931, "fmt": "1.79"}, "recommendationKey": "buy", "numberOfAnalystOpinions": {"raw": 26, "fmt": "26", "longFmt": "26"}, "totalCash": {"raw": 2724623872, "fmt": "2.72B", "longFmt": "2,724,623,872"}, "totalCashPerShare": {"raw": 20.623, "fmt": "20.62"}, "ebitda": {"raw": 321020992, "fmt": "321.02M", "longFmt": "321,020,992"}, "totalDebt": {"raw": 2773308928, "fmt": "2.77B", "longFmt": "2,773,308,928"}, "quickRatio": {"raw": 2.372, "fmt": "2.37"}, "currentRatio": {"raw": 2.541, "fmt": "2.54"}, "totalRevenue": {"raw": 3210070016, "fmt": "3.21B", "longFmt": "3,210,070,016"}, "debtToEquity": {"raw": 1185.712, "fmt": "1,185.71%"}, "revenuePerShare": {"raw": 24.65, "fmt": "24.65"}, "returnOnAssets": {"raw": 0.036530003, "fmt": "3.65%"}, "returnOnEquity": {"raw": 0.32724997, "fmt": "32.72%"}, "grossProfits": {"raw": 2693104896, "fmt": "2.69B", "longFmt": "2,693,104,896"}, "freeCashflow": {"raw": 98124000, "fmt": "98.12M", "longFmt": "98,124,000"}, "operatingCashflow": {"raw": 265863008, "fmt": "265.86M", "longFmt": "265,863,008"}, "earningsGrowth": {}, "revenueGrowth": {"raw": 1.493, "fmt": "149.30%"}, "grossMargins": {"raw": 0.83896005, "fmt": "83.90%"}, "ebitdaMargins": {"raw": 0.1, "fmt": "10.00%"}, "operatingMargins": {"raw": 0.29462, "fmt": "29.46%"}, "profitMargins": {"raw": 0.0135699995, "fmt": "1.36%"}, "financialCurrency": "USD"}}